{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:06:21Z","timestamp":1792415181584,"version":"4.4.0"},"publisher-location":"Cham","reference-count":56,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030220044","type":"print"},{"value":"9783030220051","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/164_2019_226","type":"book-chapter","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T04:03:05Z","timestamp":1562040185000},"page":"265-282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Chenodeoxycholic Acid: An Update on Its Therapeutic Applications"],"prefix":"10.1007","author":[{"given":"Stefano","family":"Fiorucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Distrutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,3]]},"reference":[{"key":"226_CR1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0016-5085(75)80015-1","volume":"68","author":"RD Adler","year":"1975","unstructured":"Adler RD, Bennion LJ, Duane WC, Grundy SM (1975) Effects of low dose chenodeoxycholic acid feeding on biliary lipid metabolism. Gastroenterology 68:326\u2013334","journal-title":"Gastroenterology"},{"key":"226_CR2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0022-2275(20)34954-3","volume":"22","author":"J Ahlberg","year":"1981","unstructured":"Ahlberg J, Angelin B, Einarsson K (1981) Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment. Lipid Res 22:410\u2013422","journal-title":"Lipid Res"},{"key":"226_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/164_2019_241","volume-title":"Handbook of Experimental Pharmacology","author":"Daniel Cabrera","year":"2019","unstructured":"Arrese M (2019) UDCA, Nor-UDCA and T-UDCA: a review of their mechanisms of action and clinical applications. Hepatology. https:\/\/doi.org\/10.1007\/164_2019_241"},{"key":"226_CR4","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1056\/NEJM198412273112601","volume":"311","author":"VM Berginer","year":"1984","unstructured":"Berginer VM, Salen G, Shefer S (1984) Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med 311:1649\u20131652","journal-title":"N Engl J Med"},{"key":"226_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/MOL.0b013e328362df13","volume":"24","author":"I Bj\u00f6rkhem","year":"2013","unstructured":"Bj\u00f6rkhem I (2013) Cerebrotendinous xanthomatosis. Curr Opin Lipidol 24:283\u2013287","journal-title":"Curr Opin Lipidol"},{"key":"226_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bbrc.2010.02.140","volume":"396","author":"I Bj\u00f6rkhem","year":"2010","unstructured":"Bj\u00f6rkhem I, Hansson M (2010) Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge. Biochem Biophys Res Commun 396:46\u201349","journal-title":"Biochem Biophys Res Commun"},{"key":"226_CR7","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1016\/S0021-9258(20)89518-0","volume":"266","author":"JJ Cali","year":"1991","unstructured":"Cali JJ, Hsieh CL, Francke U, Russell DW (1991) Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem 266:7779\u20137783","journal-title":"J Biol Chem"},{"key":"226_CR8","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1172\/JCI109025","volume":"61","author":"MC Carey","year":"1978","unstructured":"Carey MC, Small DM (1978) The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man. J Clin Investig 61:998\u20131026","journal-title":"J Clin Investig"},{"key":"226_CR1000","doi-asserted-by":"publisher","DOI":"10.1007\/164_2019_235","volume-title":"Handbook of Experimental Pharmacology","author":"Marica Cariello","year":"2019","unstructured":"Cariello M, Piglionica M, Gadaleta RA, Moschetta A (2019) The enterokine fibroblast growth factor 15\/19 in bile acid metabolism. Handb Exp Pharmacol. https:\/\/doi.org\/10.1007\/164_2019_235"},{"key":"226_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM197201062860101","volume":"286","author":"RG Danzinger","year":"1972","unstructured":"Danzinger RG, Hofmann AF, Schoenfield LJ, Thistle JL (1972) Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med 286:1\u20138","journal-title":"N Engl J Med"},{"key":"226_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000450987","volume":"35","author":"PA Dawson","year":"2017","unstructured":"Dawson PA (2017) Roles of ileal ASBT and OST\u03b1-OST\u03b2 in regulating bile acid signaling. Dig Dis 35:261\u2013266","journal-title":"Dig Dis"},{"key":"226_CR11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1530\/eje.0.1420200","volume":"142","author":"S Diederich","year":"2000","unstructured":"Diederich S, Grossmann C, Hanke B, Quinkler M, Herrmann M, Bahr V, Oelkers W (2000) In the search for specific inhibitors of human 11betahydroxysteroid-dehydrogenases (11beta-HSDs): chenodeoxycholic acid selectively inhibits 11beta-HSD-I. Eur J Endocrinol 142:200\u2013207","journal-title":"Eur J Endocrinol"},{"key":"226_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1055\/s-0030-1267170","volume":"43","author":"S Diederich","year":"2011","unstructured":"Diederich S, Quinkler M, Mai K, Sch\u00f6nesh\u00f6fer M, Baehr V, Pfeiffer A, Oelkers W, Eigendorff E (2011) In vivo activity of 11\u03b2-hydroxysteroid dehydrogenase type 1 in man: effects of prednisolone and chenodesoxycholic acid. Horm Metab Res 43:66\u201371","journal-title":"Horm Metab Res"},{"key":"226_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10072-004-0320-6","volume":"25","author":"MT Dotti","year":"2004","unstructured":"Dotti MT, L\u00fctjohann D, von Bergmann K, Federico A (2004) Normalisation of serum cholestanol concentration in a patient with cerebrotendinous xanthomatosis by combined treatment with chenodeoxycholic acid, simvastatin and LDL apheresis. Neurol Sci 25:185\u2013191","journal-title":"Neurol Sci"},{"key":"226_CR14","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jacl.2018.06.008","volume":"12","author":"PB Duell","year":"2018","unstructured":"Duell PB, Salen G, Eichler FS, DeBarber AE, Connor SL, Casaday L, Jayadev S, Kisanuki Y, Lekprasert P et al (2018) Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis. J Clin Lipidol 12:1169\u20131178","journal-title":"J Clin Lipidol"},{"key":"226_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-2275(20)39836-9","volume":"21","author":"K Einarsson","year":"1980","unstructured":"Einarsson K, Grundy SM (1980) Effects of feeding cholic acid and chenodeoxycholic acid on cholesterol absorption and hepatic secretion of biliary lipids in man. J Lipid Res 21:23\u201334","journal-title":"J Lipid Res"},{"key":"226_CR16","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1053\/jhep.2001.23790","volume":"33","author":"C Einarsson","year":"2001","unstructured":"Einarsson C, Hillebrant CG, Axelson M (2001) Effects of treatment with deoxycholic acid and chenodeoxycholic acid on the hepatic synthesis of cholesterol and bile acids in healthy subjects. Hepatology 33:1189\u20131193","journal-title":"Hepatology"},{"key":"226_CR17","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/hep.1840380419","volume":"38","author":"E Ellis","year":"2003","unstructured":"Ellis E, Axelson M, Abrahamsson A, Eggertsen G, Thorne A, Nowak G, Ericzon BG, Bjorkhem I, Einarsson C (2003) Feedback regulation of bile acid synthesis in primary human hepatocytes: evidence that CDCA is the strongest inhibitor. Hepatology 38:930\u2013938","journal-title":"Hepatology"},{"key":"226_CR18","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.molmed.2015.09.001","volume":"21","author":"S Fiorucci","year":"2015","unstructured":"Fiorucci S, Distrutti E (2015) Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders. Trends Mol Med 21:702\u2013714","journal-title":"Trends Mol Med"},{"key":"226_CR19","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/BF01537580","volume":"35","author":"S Fiorucci","year":"1990","unstructured":"Fiorucci S, Bosso R, Scionti L, Disanto S, Annibale B, Delle Fave G, Morelli A (1990) Neurohumoral control of gallbladder motility in healthy subjects and diabetic patients with or without autonomic neuropathy. Dig Dis Sci 35:1089\u20131097","journal-title":"Dig Dis Sci"},{"key":"226_CR20","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1007\/BF01299858","volume":"37","author":"S Fiorucci","year":"1992","unstructured":"Fiorucci S, Bosso R, Morelli A (1992a) Erythromycin stimulates gallbladder emptying and motilin release by atropine-sensitive pathways. Dig Dis Sci 37:1678\u20131684","journal-title":"Dig Dis Sci"},{"key":"226_CR21","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/BF01299857","volume":"37","author":"S Fiorucci","year":"1992","unstructured":"Fiorucci S, Scionti L, Bosso R, Desando A, Bottini P, Marino C, Morelli A (1992b) Effect of erythromycin on gallbladder emptying in diabetic patients with and without autonomic neuropathy and high levels of motilin. Dig Dis Sci 37:1671\u20131677","journal-title":"Dig Dis Sci"},{"key":"226_CR22","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1053\/j.gastro.2004.08.001","volume":"127","author":"S Fiorucci","year":"2004","unstructured":"Fiorucci S, Antonelli E, Rizzo G, Renga B, Mencarelli A, Riccardi L, Orlandi S, Pellicciari R, Morelli A (2004) The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. Gastroenterology 127:1497\u20131512","journal-title":"Gastroenterology"},{"key":"226_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.phrs.2018.07.014","volume":"134","author":"S Fiorucci","year":"2018","unstructured":"Fiorucci S, Biagioli M, Distrutti E (2018a) Future trends in the treatment of non-alcoholic steatohepatitis. Pharmacol Res 134:289\u2013298","journal-title":"Pharmacol Res"},{"key":"226_CR24","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3389\/fimmu.2018.01853","volume":"9","author":"S Fiorucci","year":"2018","unstructured":"Fiorucci S, Biagioli M, Zampella A, Distrutti E (2018b) Bile acids activated receptors regulate innate immunity. Front Immunol 9:1853","journal-title":"Front Immunol"},{"key":"226_CR25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00415-012-6630-3","volume":"260","author":"F Ginanneschi","year":"2013","unstructured":"Ginanneschi F, Mignarri A, Mondelli M, Gallus GN, Del Puppo M, Giorgi S, Federico A, Rossi A, Dotti MT (2013) Polyneuropathy in cerebrotendinous xanthomatosis and response to treatment with chenodeoxycholic acid. J Neurol 260:268\u2013274","journal-title":"J Neurol"},{"key":"226_CR26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1210\/me.2002-0246","volume":"17","author":"B Goodwin","year":"2003","unstructured":"Goodwin B, Watson MA, Kim H, Miao J, Kemper JK, Kliewer SA (2003) Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha. Mol Endocrinol 17:386\u2013394","journal-title":"Mol Endocrinol"},{"key":"226_CR27","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/dom.12648","volume":"18","author":"M Hansen","year":"2016","unstructured":"Hansen M, Scheltema MJ, Sonne DP, Hansen JS, Sperling M, Rehfeld JF, Holst JJ, Vilsb\u00f8ll T, Knop FK (2016) Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion. Diabetes Obes Metab 18:571\u2013580","journal-title":"Diabetes Obes Metab"},{"key":"226_CR28","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0022-2275(20)34421-7","volume":"25","author":"AF Hofmann","year":"1984","unstructured":"Hofmann AF, Roda A (1984) Physicochemical properties of bile acids and their relationship to biological properties: an overview of the problem. J Lipid Res 25:1477\u20131489","journal-title":"J Lipid Res"},{"key":"226_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00431-015-2584-7","volume":"175","author":"HH Huidekoper","year":"2016","unstructured":"Huidekoper HH, Vaz FM, Verrips A, Bosch AM (2016) Hepatotoxicity due to chenodeoxycholic acid supplementation in an infant with cerebrotendinous xanthomatosis: implications for treatment. Eur J Pediatr 175:143\u2013146","journal-title":"Eur J Pediatr"},{"key":"226_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.5009\/gnl15015","volume":"9","author":"JJ Hyun","year":"2015","unstructured":"Hyun JJ, Lee HS, Kim CD, Dong SH, Lee SO, Ryu JK, Lee DH, Jeong S, Kim TN et al (2015) Efficacy of magnesium trihydrate of ursodeoxycholic acid and chenodeoxycholic acid for gallstone dissolution: a prospective multicenter trial. Gut and Liver 9:547\u2013555","journal-title":"Gut and Liver"},{"key":"226_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","volume":"2","author":"T Inagaki","year":"2005","unstructured":"Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, Luo G, Jones SA, Goodwin B et al (2005) Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2:217\u2013225","journal-title":"Cell Metab"},{"key":"226_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jns.2003.07.005","volume":"216","author":"S Ito","year":"2003","unstructured":"Ito S, Kuwabara S, Sakakibara R, Oki T, Arai H, Oda S, Hattori T (2003) Combined treatment with LDL-apheresis, chenodeoxycholic acid and HMG-CoA reductase inhibitor for cerebrotendinous xanthomatosis. J Neurol Sci 216:179\u2013182","journal-title":"J Neurol Sci"},{"key":"226_CR1001","doi-asserted-by":"crossref","unstructured":"Keitel V, Dr\u00f6ge C, H\u00e4ussinger D (2019) Targeting FXR in cholestasis. Handb Exp Pharmacol","DOI":"10.1007\/164_2019_231"},{"key":"226_CR33","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1053\/j.gastro.2003.06.005","volume":"126","author":"GA Kullak-Ublick","year":"2004","unstructured":"Kullak-Ublick GA, Stieger B, Meier PJ (2004) Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 126:322\u2013342","journal-title":"Gastroenterology"},{"key":"226_CR34","doi-asserted-by":"publisher","first-page":"16024","DOI":"10.1038\/nrdp.2016.24","volume":"2","author":"F Lammert","year":"2016","unstructured":"Lammert F, Gurusamy K, Ko CW, Miquel JF, M\u00e9ndez-S\u00e1nchez N, Portincasa P, van Erpecum KJ, van Laarhoven CJ, Wang DQ (2016) Gallstones. Nat Rev Dis Primers 2:16024","journal-title":"Nat Rev Dis Primers"},{"key":"226_CR35","doi-asserted-by":"publisher","first-page":"e2037","DOI":"10.1097\/MD.0000000000002037","volume":"94","author":"JM Lee","year":"2015","unstructured":"Lee JM, Hyun JJ, Choi IY, Yeom SK, Kim SY, Jung SW, Jung YK, Koo JS, Yim HJ et al (2015) Comparison on response and dissolution rates between ursodeoxycholic acid alone or in combination with chenodeoxycholic acid for gallstone dissolution according to stone density on CT scan: strobe compliant observation study. Medicine (Baltimore) 94:e2037","journal-title":"Medicine (Baltimore)"},{"key":"226_CR36","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1124\/pr.113.008201","volume":"66","author":"T Li","year":"2014","unstructured":"Li T, Chiang JY (2014) Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev 66:948\u2013983","journal-title":"Pharmacol Rev"},{"key":"226_CR37","first-page":"690","volume":"72","author":"I Makino","year":"1975","unstructured":"Makino I, Shinozaki K, Yoshino K, Nakagawa S (1975) Dissolution of cholesterol gallstones by ursodeoxycholic acid. Jpn J Gastroenterol 72:690\u2013702","journal-title":"Jpn J Gastroenterol"},{"key":"226_CR38","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","volume":"284","author":"M Makishima","year":"1999","unstructured":"Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ et al (1999) Identification of a nuclear receptor for bile acids. Science 284:1362\u20131365","journal-title":"Science"},{"key":"226_CR39","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s00223-012-9677-3","volume":"92","author":"G Martini","year":"2013","unstructured":"Martini G, Mignarri A, Ruvio M, Valenti R, Franci B, Del Puppo M, Federico A, Nuti R, Dotti MT (2013) Long-term bone density evaluation in cerebrotendinous xanthomatosis: evidence of improvement after chenodeoxycholic acid treatment. Calcif Tissue Int 92:282\u2013286","journal-title":"Calcif Tissue Int"},{"key":"226_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1365-2036.1993.tb00082.x","volume":"7","author":"GR May","year":"1993","unstructured":"May GR, Sutherland LR, Shaffer EA (1993) Efficacy of bile acid therapy for gallstone dissolution: a meta-analysis of randomized trials. Aliment Pharmacol Ther 7:139\u2013148","journal-title":"Aliment Pharmacol Ther"},{"key":"226_CR41","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1210\/jc.2012-4109","volume":"98","author":"AC Meyer-Gerspach","year":"2013","unstructured":"Meyer-Gerspach AC, Steinert RE, Keller S, Malarski A, Schulte FH, Beglinger C (2013) Effects of chenodeoxycholic acid on the secretion of gut peptides and fibroblast growth factors in healthy humans. J Clin Endocrinol Metab 98:3351\u20133358","journal-title":"J Clin Endocrinol Metab"},{"key":"226_CR42","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1038\/nm1138","volume":"10","author":"A Moschetta","year":"2004","unstructured":"Moschetta A, Bookout AL, Mangelsdorf DJ (2004) Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med 10:1352\u20131358","journal-title":"Nat Med"},{"key":"226_CR43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jpba.2013.06.029","volume":"87","author":"B Natalini","year":"2014","unstructured":"Natalini B, Sardella R, Gioiello A, Ianni F, Di Michele A, Marinozzi M (2014) Determination of bile salt critical micellization concentration on the road to drug discovery. J Pharm Biomed Anal 87:62\u201381","journal-title":"J Pharm Biomed Anal"},{"key":"226_CR44","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13023-014-0179-4","volume":"9","author":"S Nie","year":"2014","unstructured":"Nie S, Chen G, Cao X, Zhang Y (2014) Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. Orphanet J Rare Dis 9:179","journal-title":"Orphanet J Rare Dis"},{"key":"226_CR45","doi-asserted-by":"publisher","first-page":"e13140","DOI":"10.14814\/phy2.13140","volume":"5","author":"S Nielsen","year":"2017","unstructured":"Nielsen S, Svane MS, Kuhre RE, Clausen TR, Kristiansen VB, Rehfeld JF, Holst JJ, Madsbad S, Bojsen-Moller KN (2017) Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass. Physiol Rep 5:e13140","journal-title":"Physiol Rep"},{"key":"226_CR46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tem.2014.10.002","volume":"26","author":"BM Owen","year":"2015","unstructured":"Owen BM, Mangelsdorf DJ, Kliewer SA (2015) Tissue-specific actions of the metabolic hormones FGF15\/19 and FGF21. Trends Endocrinol Metab 26:22\u201329","journal-title":"Trends Endocrinol Metab"},{"key":"226_CR47","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","volume":"284","author":"DJ Parks","year":"1999","unstructured":"Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM et al (1999) Bile acids: natural ligands for an orphan nuclear receptor. Science 284:1365\u20131368","journal-title":"Science"},{"key":"226_CR48","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1007\/BF02208664","volume":"40","author":"ML Petroni","year":"1995","unstructured":"Petroni ML, Jazrawi RP, Grundy A, Lanzini A, Pigozzi MG, Biasio A, Heaton KW, Virjee J, Northfield TC (1995) Prospective, multicenter study on value of computerized tomography (CT) in gallstone disease in predicting response to bile acid therapy. Dig Dis Sci 40:1956\u20131962","journal-title":"Dig Dis Sci"},{"key":"226_CR49","doi-asserted-by":"publisher","first-page":"257","DOI":"10.7326\/0003-4819-95-3-257","volume":"95","author":"LJ Schoenfield","year":"1981","unstructured":"Schoenfield LJ, Lachin JM (1981) Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: The National Cooperative Gallstone Study. A controlled trial of efficacy and safety. Ann Intern Med 95:257\u2013282","journal-title":"Ann Intern Med"},{"key":"226_CR50","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1126\/science.272.5266.1336","volume":"272","author":"W Seol","year":"1996","unstructured":"Seol W, Choi HS, Moore DD (1996) An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 272:1336\u20131339","journal-title":"Science"},{"key":"226_CR1002","doi-asserted-by":"crossref","unstructured":"Shin D-J, Wang L (2019) Bile acid activated receptors: a review on FXR and other nuclear receptors. Handb Exp Pharmacol","DOI":"10.1007\/164_2019_236"},{"key":"226_CR51","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","volume":"3","author":"H Wang","year":"1999","unstructured":"Wang H, Chen J, Hollister K, Sowers LC, Forman BM (1999) Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR. Mol Cell 3:543\u2013553","journal-title":"Mol Cell"},{"key":"226_CR52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.lab.2006.03.009","volume":"148","author":"Y Wang","year":"2006","unstructured":"Wang Y, Jones PJ, Woollett LA, Buckley DD, Yao L, Granholm NA, Tolley EA, Heubi JE (2006) Effects of chenodeoxycholic acid and deoxycholic acid on cholesterol absorption and metabolism in humans. Transl Res 148:37\u201345","journal-title":"Transl Res"},{"key":"226_CR53","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.bbadis.2010.10.006","volume":"1812","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Hagedorn CH, Wang L (2011) Role of nuclear receptor SHP in metabolism and cancer. Biochim Biophys Acta 1812:893\u2013908","journal-title":"Biochim Biophys Acta"}],"container-title":["Handbook of Experimental Pharmacology","Bile Acids and Their Receptors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2019_226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T23:08:14Z","timestamp":1610147294000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2019_226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030220044","9783030220051"],"references-count":56,"URL":"https:\/\/doi.org\/10.1007\/164_2019_226","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"3 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}